回复维尔曼等人。对“罗森茨韦格等人。极低的前列腺PET/CT PSMA摄取在前列腺癌根治术候选患者分期中可能具有误导性。2022年，，410”的评论
Reply to Veerman et al. Comment on "Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. 2022, , 410".
作者信息
Rosenzweig Barak, Haramaty Rennen, Davidson Tima, Lazarovich Alon, Shvero Asaf, Haifler Miki, Gal Jonathan, Golan Shay, Shpitzer Sagi, Hoffman Azik, Nativ Omri, Freifeld Yuval, Zreik Rani, Dotan Zohar A
机构信息
Department of Urology, Chaim Sheba Medical Center, Ramat Gan 5211401, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
出版信息
J Pers Med. 2022 May 25;12(6):861. doi: 10.3390/jpm12060861.
Abstract
We thank the commenters for their important insights [...].
摘要
我们感谢评论者们提出的重要见解[...]。
相似文献
1
Reply to Veerman et al. Comment on "Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. 2022, , 410".回复维尔曼等人。对“罗森茨韦格等人。极低的前列腺PET/CT PSMA摄取在前列腺癌根治术候选患者分期中可能具有误导性。2022年，，410”的评论
J Pers Med. 2022 May 25;12(6):861. doi: 10.3390/jpm12060861.
2
Comment on Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. 2022, , 410.对罗森茨韦格等人的评论。前列腺PET/CT中极低的前列腺特异性膜抗原（PSMA）摄取在前列腺癌根治术候选患者分期中可能具有误导性。2022年，，410。
J Pers Med. 2022 May 16;12(5):800. doi: 10.3390/jpm12050800.
3
How accurate is Gallium-prostate specific membrane antigen positron emission tomography / computed tomography (Ga-PSMA PET/CT) on primary lymph node staging before radical prostatectomy in intermediate and high risk prostate cancer? A study of patient- and lymph node- based analyses.镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描（Ga-PSMA PET/CT）在中高危前列腺癌根治性前列腺切除术前对原发性淋巴结分期的准确性如何？一项基于患者和淋巴结的分析研究。
Urol Oncol. 2022 Jan;40(1):6.e1-6.e9. doi: 10.1016/j.urolonc.2021.07.006. Epub 2021 Aug 13.
4
Histological comparison between predictive value of preoperative 3-T multiparametric MRI and Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer.术前 3-T 多参数 MRI 和 Ga-PSMA PET/CT 扫描对前列腺癌根治性前列腺切除术和盆腔淋巴结清扫术病理结果的预测价值的组织学比较。
BJU Int. 2021 Jan;127(1):71-79. doi: 10.1111/bju.15134. Epub 2020 Sep 7.
5
Ga-PSMA-11 Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging Before Radical Prostatectomy: Central Review of Imaging and Comparison with Histopathology of Extended Lymphadenectomy.镓-PSMA-11正电子发射断层扫描/计算机断层扫描用于根治性前列腺切除术前行原发性淋巴结分期：影像学的中心回顾及与扩大淋巴结清扫术组织病理学的比较
Eur Urol Focus. 2021 Mar;7(2):288-293. doi: 10.1016/j.euf.2021.01.004. Epub 2021 Jan 25.
6
Ga-PSMA PET/CT Imaging Predicting Intraprostatic Tumor Extent, Extracapsular Extension and Seminal Vesicle Invasion Prior to Radical Prostatectomy in Patients with Prostate Cancer.镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描成像预测前列腺癌患者根治性前列腺切除术前前列腺内肿瘤范围、包膜外侵犯及精囊侵犯情况
Nucl Med Mol Imaging. 2017 Dec;51(4):314-322. doi: 10.1007/s13139-017-0476-7. Epub 2017 Mar 7.
7
Gallium-68-prostate-specific membrane antigen ( Ga-PSMA) positron emission tomography (PET)/computed tomography (CT) predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate- and high-risk prostate cancer.镓-68-前列腺特异性膜抗原（Ga-PSMA）正电子发射断层扫描（PET）/计算机断层扫描（CT）可预测中高危前列腺癌根治性前列腺切除术和淋巴结清扫术后的完全生化缓解。
BJU Int. 2019 Jul;124(1):62-68. doi: 10.1111/bju.14506. Epub 2019 Apr 7.
8
Primary lymph-node staging with Ga-PSMA PET in high-risk prostate cancer: pathologic correlation with extended pelvic lymphadenectomy specimens.高危前列腺癌中 Ga-PSMA PET 进行初级淋巴结分期：与扩大盆腔淋巴结清扫标本的病理相关性。
Urol Oncol. 2021 Aug;39(8):494.e1-494.e6. doi: 10.1016/j.urolonc.2020.10.074. Epub 2020 Nov 19.
9
Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment strategy.镓-PSMA-11 PET/CT 在根治性前列腺切除术后生化复发且 PSA<0.5ng/ml 的前列腺癌患者中的应用。疗效及对治疗策略的影响。
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):11-19. doi: 10.1007/s00259-018-4066-4. Epub 2018 Jun 15.
10
Ga-PSMA PET/CT based primary staging and histological correlation after extended pelvic lymph node dissection at radical prostatectomy.基于镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描（Ga-PSMA PET/CT）的根治性前列腺切除术中扩大盆腔淋巴结清扫术后的初始分期及组织学相关性研究
World J Urol. 2020 Dec;38(12):3085-3090. doi: 10.1007/s00345-020-03131-0. Epub 2020 Feb 26.
引用本文的文献
1
Imaging Efficacy of [F]CTT1057 PET for the Detection of PSMA-Positive Tumors Using Histopathology as Standard of Truth: Results from the GuideView Phase 2/3 Prospective Multicenter Study.以组织病理学为金标准评估[F]CTT1057 PET检测PSMA阳性肿瘤的成像效能：GuideView 2/3期前瞻性多中心研究结果
J Nucl Med. 2025 Aug 1;66(8):1232-1238. doi: 10.2967/jnumed.124.269007.
2
Enhancing Prostate Cancer Staging: Association of 68Ga-PSMA PET/CT Imaging with Histopathological Grading in Treatment-Naive Patients.提高前列腺癌分期：初治患者中68Ga-PSMA PET/CT成像与组织病理学分级的相关性
Cancers (Basel). 2024 Oct 18;16(20):3526. doi: 10.3390/cancers16203526.
3
Direct Patlak Reconstruction of [Ga]Ga-PSMA PET for the Evaluation of Primary Prostate Cancer Prior Total Prostatectomy: Results of a Pilot Study.直接 Patlak 重建[Ga]Ga-PSMA PET 用于评估全前列腺切除术后原发性前列腺癌：一项初步研究的结果。
Int J Mol Sci. 2023 Sep 5;24(18):13677. doi: 10.3390/ijms241813677.
4
PSMA PET-CT in the Diagnosis and Staging of Prostate Cancer.前列腺特异性膜抗原正电子发射断层扫描计算机断层扫描在前列腺癌诊断及分期中的应用
Diagnostics (Basel). 2022 Oct 26;12(11):2594. doi: 10.3390/diagnostics12112594.
5
Comment on Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. 2022, , 410.对罗森茨韦格等人的评论。前列腺PET/CT中极低的前列腺特异性膜抗原（PSMA）摄取在前列腺癌根治术候选患者分期中可能具有误导性。2022年，，410。
J Pers Med. 2022 May 16;12(5):800. doi: 10.3390/jpm12050800.
本文引用的文献
1
Comment on Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. 2022, , 410.对罗森茨韦格等人的评论。前列腺PET/CT中极低的前列腺特异性膜抗原（PSMA）摄取在前列腺癌根治术候选患者分期中可能具有误导性。2022年，，410。
J Pers Med. 2022 May 16;12(5):800. doi: 10.3390/jpm12050800.
2
What's behind Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patterns.Ga-PSMA-11 在原发性前列腺癌 PET 中的摄取背后是什么？对组织病理学参数和免疫组织化学 PSMA 表达模式的调查。
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):4042-4053. doi: 10.1007/s00259-021-05501-1. Epub 2021 Aug 13.
3
False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial.阳性前列腺特异性膜抗原 PET 预测前列腺癌根治术后肿瘤残留：一项前瞻性多中心研究
Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):501-508. doi: 10.1007/s00259-020-04945-1. Epub 2020 Aug 17.
4
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.高风险前列腺癌患者在接受根治性手术或放疗前的前列腺特异性膜抗原 PET-CT（proPSMA）：一项前瞻性、随机、多中心研究。
Lancet. 2020 Apr 11;395(10231):1208-1216. doi: 10.1016/S0140-6736(20)30314-7. Epub 2020 Mar 22.
5
Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour.镓-PSMA-11 PET/CT在前列腺癌初始分期中的应用：前列腺特异抗原（PSA）和 Gleason评分可预测原发肿瘤中示踪剂摄取强度。
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):941-949. doi: 10.1007/s00259-017-3631-6. Epub 2017 Jan 31.
6
68Ga-PSMA PET/CT False-Positive Tracer Uptake in Paget Disease.68Ga-PSMA PET/CT 假阳性摄取在 Pagets 病中的应用。
Clin Nucl Med. 2016 Oct;41(10):e454-5. doi: 10.1097/RLU.0000000000001340.
7
Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.68镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描对前列腺癌术前淋巴结分期的前瞻性评估
BJU Int. 2017 Feb;119(2):209-215. doi: 10.1111/bju.13540. Epub 2016 Jun 18.
Zotero 插件